Legislative and Regulatory Trends

(L2) Federal Legislative and Regulatory Update

Wednesday, March 22, 2023

10:30 AM – 11:45 AM

Location: B1

ACPE UAN:0233-0000-23-003-L03-P | Contact Hours: 1.25 | Activity Type: Knowledge-based

Faculty(s)

Jennifer L. Mathieu, MA (she/her/hers)

Vice President, Policy and Government Relations
AMCP
Alexandria, VA
Geni Tunstall, JD (she/her/hers)

Director, Regulatory Affairs
AMCP
Alexandria, VA

Moderator(s)

TT

Tyler Thorne

Coordinator, Policy & Government Relations
AMCP
Alexandria, Virginia

Join AMCP Policy & Government Relations staff for a discussion on the federal activity regarding health policy. This session will focus on AMCP’s priority issues, including prescription digital therapeutics and performance-based reimbursement. Other bills and regulations relevant to managed care pharmacy being considered by the newly-seated 118th Congress or Biden administration, or anticipated for consideration in 2023, will also be presented.

Learning Objectives::

At the completion of this activity, participants should be able to:

Identify the must-pass health care legislation recently signed into law and its major provisions.
Describe at least two federal health legislative proposals anticipated in the coming year.
Summarize the Biden administration’s recent regulatory action that will impact the practices of managed care pharmacy professionals and teams.